drugset / Trial / NCT02205840

A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.

NCT02205840 ↗

Phase 2/3 Completed 240 enrolled Seikagaku Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the safety and effectiveness of SI-614 solution compared with placebo solution in treating patients with dry eye.

Timeline

Start
2014-07
Primary completion
2014-11
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject CINHYALURONATE SODIUM Unknown — Other

Indications